Research
Hormonal
Lifestyle changes may impact cardiovascular outcomes in type 2 diabetes.
Encouraging lifestyle changes may be beneficial for cardiovascular health in patients with type 2 diabetes.
StrongSupportsmedium confidence
The role of lifestyle changes on cardiovascular outcomes will be also addressed.
Why this rating
The claim is supported by the review's intent to address lifestyle changes.
Source
Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?
Francesco Giorgino et al. · Diabetes Care · 2016
DOI 10.2337/dcs15-3023
reviewCited 53×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →